A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 151,075 shares of ARDX stock, worth $778,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares
151,075
Previous 141,341 6.89%
Holding current value
$778,036
Previous $1.05 Million 0.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.28 - $7.57 $51,395 - $73,686
9,734 Added 6.89%
151,075 $1.04 Million
Q2 2024

Aug 14, 2024

BUY
$5.89 - $9.31 $832,498 - $1.32 Million
141,341 New
141,341 $1.05 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $796M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.